AllianceBernstein’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.04M Sell
173,347
-14,947
-8% -$260K ﹤0.01% 1994
2025
Q4
$2.22M Buy
188,294
+20,408
+12% +$262K ﹤0.01% 1936
2025
Q3
$2.66M Buy
167,886
+1,756
+1% +$25.5K ﹤0.01% 1851
2025
Q2
$1.9M Buy
166,130
+121,092
+269% +$1.36M ﹤0.01% 1961
2025
Q1
$609K Sell
45,038
-130,660
-74% -$2.17M ﹤0.01% 2471
2024
Q4
$2.97M Sell
175,698
-2,876
-2% -$56K ﹤0.01% 1762
2024
Q3
$3.63M Sell
178,574
-21,362
-11% -$437K ﹤0.01% 1673
2024
Q2
$4.51M Sell
199,936
-29,531
-13% -$773K ﹤0.01% 1529
2024
Q1
$6.03M Sell
229,467
-18,694
-8% -$533K ﹤0.01% 1396
2023
Q4
$7.83M Buy
248,161
+13,931
+6% +$378K ﹤0.01% 1285
2023
Q3
$6.57M Sell
234,230
-4,496
-2% -$154K ﹤0.01% 1304
2023
Q2
$8.81M Buy
238,726
+19,454
+9% +$594K ﹤0.01% 1188
2023
Q1
$6.57M Sell
219,272
-14,073
-6% -$464K ﹤0.01% 1289
2022
Q4
$7.15M Sell
233,345
-3,540
-1% -$106K ﹤0.01% 1255
2022
Q3
$5.84M Sell
236,885
-3,604
-1% -$119K ﹤0.01% 1336
2022
Q2
$7.7M Sell
240,489
-2,623
-1% -$96.5K ﹤0.01% 1237
2022
Q1
$7.65M Sell
243,112
-4,265
-2% -$133K ﹤0.01% 1382
2021
Q4
$8.3M Sell
247,377
-5,274
-2% -$164K ﹤0.01% 1346
2021
Q3
$7.34M Sell
252,651
-5,087
-2% -$165K ﹤0.01% 1409
2021
Q2
$8.97M Sell
257,738
-5,465
-2% -$181K ﹤0.01% 1291
2021
Q1
$7.35M Buy
263,203
+3,327
+1% +$88.5K ﹤0.01% 1357
2020
Q4
$6.44M Sell
259,876
-7,710
-3% -$183K ﹤0.01% 1351
2020
Q3
$5.59M Sell
267,586
-1,801
-0.7% -$34.8K ﹤0.01% 1290
2020
Q2
$4.13M Sell
269,387
-31,599
-10% -$399K ﹤0.01% 1434
2020
Q1
$2.67M Sell
300,986
-1,932
-0.6% -$27.9K ﹤0.01% 1505
2019
Q4
$5.48M Buy
302,918
+18,740
+7% +$311K ﹤0.01% 1382
2019
Q3
$4.25M Sell
284,178
-8,891
-3% -$145K ﹤0.01% 1495
2019
Q2
$7.03M Sell
293,069
-8,067
-3% -$238K ﹤0.01% 1222
2019
Q1
$11.2M Sell
301,136
-12,426
-4% -$452K 0.01% 1009
2018
Q4
$8.85M Buy
313,562
+174,041
+125% +$5.51M 0.01% 1035
2018
Q3
$5.5M Sell
139,521
-62,368
-31% -$2.73M ﹤0.01% 1230
2018
Q2
$8.96M Buy
201,889
+48,839
+32% +$2.43M 0.01% 1009
2018
Q1
$7.46M Sell
153,050
-4,234
-3% -$212K 0.01% 1037
2017
Q4
$7.87M Buy
157,284
+24,950
+19% +$1.31M 0.01% 1024
2017
Q3
$6.7M Buy
132,334
+13,380
+11% +$631K 0.01% 1079
2017
Q2
$4.51M Sell
118,954
-226,450
-66% -$8.93M ﹤0.01% 1269
2017
Q1
$13.3M Buy
345,404
+56,624
+20% +$1.7M 0.01% 865
2016
Q4
$6.38M Sell
288,780
-2,587
-0.9% -$53.1K 0.01% 1063
2016
Q3
$4.66M Sell
291,367
-5,907
-2% -$67.5K ﹤0.01% 1159
2016
Q2
$2.45M Buy
297,274
+206,856
+229% +$1.84M ﹤0.01% 1535
2016
Q1
$633K Sell
90,418
-35,072
-28% -$176K ﹤0.01% 2325
2015
Q4
$673K Sell
125,490
-9,066
-7% -$57.9K ﹤0.01% 2331
2015
Q3
$871K Buy
+134,556
New +$1.41M ﹤0.01% 2237

Other funds holding CC

AllianceBernstein's CC Position: Q1 2026 in Review

AllianceBernstein reduced its Chemours (CC) stake by 7.9% in Q1 2026, selling an estimated $260K and leaving 173,347 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1994.

AllianceBernstein first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $13.3M in Q1 2017. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • AllianceBernstein held 173,347 shares of Chemours worth $2.04M as of Q1 2026.
  • AllianceBernstein sold 14,947 Chemours shares in Q1 2026, an estimated $260K.
  • Chemours made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1994 holding.
  • AllianceBernstein first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
  • AllianceBernstein's Chemours position peaked at $13.3M in Q1 2017.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.